The latest announcement is out from Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ).
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has provided an update regarding the deposit and use of net proceeds from a previous share placement. The company issued 29,564,356 A-shares at RMB 28.28 per share, resulting in net proceeds of approximately RMB 814,340,000. This update aligns with regulatory guidelines from the China Securities Regulatory Commission and the Shanghai Stock Exchange, ensuring transparency and compliance in the management of funds.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, is a company incorporated in the People’s Republic of China. It operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products.
YTD Price Performance: 4.14%
Technical Sentiment Signal: Sell
Current Market Cap: €3.67B
Find detailed analytics on 2TZ stock on TipRanks’ Stock Analysis page.